We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Atherogenics (MM) | NASDAQ:AGIX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.07 | 0 | 01:00:00 |
Georgia | 0-31261 | 58-2108232 | ||
(State or other jurisdiction | (Commission | (I.R.S. Employer | ||
of incorporation) | File Number) | Identification Number) |
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Exhibit No. | Description | |
|
||
99.1
|
Press Release, dated September 10, 2008 |
ATHEROGENICS, INC.
|
||||
Date: September 10, 2008 | By: | /s/ Mark P. Colonnese | ||
Mark P. Colonnese | ||||
Executive Vice President,
Commercial Operations
and Chief Financial Officer |
||||
Exhibit No. | Description | |
|
||
99.1
|
Press Release, dated September 10, 2008 |
1 Year Atherogenics Chart |
1 Month Atherogenics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions